Helge Karch

Active 1985–2020

123
Papers
24,988
Citations
95
h-index
123
i10-index

Citations

Citations per year for Helge Karch1986: 2 citations1987: 18 citations1988: 11 citations1989: 28 citations1990: 30 citations1991: 23 citations1992: 33 citations1993: 48 citations1994: 42 citations1995: 66 citations1996: 64 citations1997: 58 citations1998: 159 citations1999: 162 citations2000: 170 citations2001: 175 citations2002: 186 citations2003: 255 citations2004: 234 citations2005: 239 citations2006: 164 citations2007: 216 citations2008: 198 citations2009: 191 citations2010: 181 citations2011: 207 citations2012: 283 citations2013: 233 citations2014: 231 citations2015: 136 citations2016: 134 citations2017: 110 citations2018: 105 citations2019: 467 citations2020: 501 citations2021: 442 citations2022: 289 citations2023: 194 citations2024: 268 citations2025: 103 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,200 citing papers, 21.1% of this breakdownGermany: 553 citing papers, 9.7% of this breakdownUnited Kingdom: 378 citing papers, 6.6% of this breakdownFrance: 316 citing papers, 5.6% of this breakdownChina: 312 citing papers, 5.5% of this breakdownCanada: 233 citing papers, 4.1% of this breakdownAustralia: 191 citing papers, 3.4% of this breakdownSpain: 162 citing papers, 2.8% of this breakdownNetherlands: 157 citing papers, 2.8% of this breakdownItaly: 154 citing papers, 2.7% of this breakdownJapan: 136 citing papers, 2.4% of this breakdownDenmark: 119 citing papers, 2.1% of this breakdown
0%21.1%Other 31.2%

Fields

  • Biochemistry, Genetics and Molecular Biology67.3%
  • Medicine10.9%
  • Immunology and Microbiology8.7%
  • Agricultural and Biological Sciences4.6%
  • Environmental Science3.7%
  • Dentistry1.5%
  • Other3.3%

Topics

  • Escherichia coli research studies17.1%
  • Viral gastroenteritis research and epidemiology9.1%
  • Antibiotic Resistance in Bacteria7.4%
  • Salmonella and Campylobacter epidemiology4.5%
  • Bacteriophages and microbial interactions4.1%
  • Bacterial Genetics and Biotechnology2.7%
  • Other55.1%

Coauthors

All papers

Open in search
  1. Sex and virulence in Escherichia coli: an evolutionary perspective

    Authors: , , , , , , , , , , - Molecular Microbiology 2006 cited by 2,017

  2. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury

    Authors: , , , , , , , , , , , , , , - PLoS Pathogens 2017 cited by 233

  3. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB

    Authors: , , , , , - International Journal of Medical Microbiology 2018 cited by 95

  4. Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Microbiology 2012 cited by 824

  5. Enterohemorrhagic Escherichia coli Hemolysin Employs Outer Membrane Vesicles to Target Mitochondria and Cause Endothelial and Epithelial Apoptosis

    Authors: , , , , , , , , , , - PLoS Pathogens 2013 cited by 205

  6. Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7

    Authors: , , , , - Antimicrobial Agents and Chemotherapy 2017 cited by 80

  7. Genetic Structure and Distribution of the Colibactin Genomic Island among Members of the Family Enterobacteriaceae

    Authors: , , , , , , , , , , , , , , - Infection and Immunity 2009 cited by 320

  8. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

    Authors: , , , , , , , - The Lancet Infectious Diseases 2011 cited by 760

  9. Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain

    Authors: , , , , , , , , , , , , , , - Scientific Reports 2015 cited by 161

  10. Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain

    Authors: , , , , , , , - Antimicrobial Agents and Chemotherapy 2012 cited by 198

  11. Dissemination of the blaCTX-M-15 gene among Enterobacteriaceae via outer membrane vesicles

    Authors: , , , - Journal of Antimicrobial Chemotherapy 2020 cited by 47

  12. Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology

    Authors: , , , , , , , , , , , , , , , , , , , - PLoS ONE 2011 cited by 771

  13. Identification of Unconventional Intestinal Pathogenic Escherichia coli Isolates Expressing Intermediate Virulence Factor Profiles by Using a Novel Single-Step Multiplex PCR

    Authors: , , , , , , - Applied and Environmental Microbiology 2007 cited by 236

  14. Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection

    Authors: , , , , , , , , , - Journal of Clinical Microbiology 2013 cited by 169

  15. Escherichia coliHarboring Shiga Toxin 2 Gene Variants: Frequency and Association with Clinical Symptoms

    Authors: , , , , , , - The Journal of Infectious Diseases 2002 cited by 722

  16. Enterohaemorrhagic Escherichia coli in human medicine

    Authors: , , - International Journal of Medical Microbiology 2005 cited by 677

  17. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V

    Authors: , , - Molecular Microbiology 1997 cited by 377

  18. Typing of Intimin Genes in Human and Animal Enterohemorrhagic and EnteropathogenicEscherichia coli: Characterization of a New Intimin Variant

    Authors: , , , , , - Infection and Immunity 2000 cited by 428

  19. Shiga toxin-encoding bacteriophages – genomes in motion

    Authors: , , - International Journal of Medical Microbiology 2004 cited by 262

  20. Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2012 cited by 184

  21. A New Shiga Toxin 2 Variant (Stx2f) from Escherichia coli Isolated from Pigeons

    Authors: , , , , , - Applied and Environmental Microbiology 2000 cited by 321

  22. EspP, a Serine Protease of EnterohemorrhagicEscherichia coli, Impairs Complement Activation by Cleaving Complement Factors C3/C3b and C5

    Authors: , , , , , , , , - Infection and Immunity 2010 cited by 77

  23. PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells

    Authors: , , , , , - Glycobiology 2019 cited by 27

  24. Prevalence of the “High-Pathogenicity Island” of Yersinia Species among Escherichia coli Strains That Are Pathogenic to Humans

    Authors: , , , , - Infection and Immunity 1998 cited by 386